- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03386123
A Comparison of CBTi and Usual Treatment for Tinnitus Related Insomnia
A Comparison of Cognitive Behaviour Therapy for Insomnia (CBTi) and Usual Audiological Rehabilitation in the Management of Tinnitus Related Insomnia
There is evidence that CBT for insomnia (CBTi) is an effective treatment for sleep disturbance both as a primary problem and when co-morbid with other health problems, such as chronic pain.
This study will investigate the effectiveness of CBTi as a treatment for tinnitus related insomnia. Tinnitus patients reporting clinically significant insomnia will be offered sleep-specific treatment. Six sessions of CBTi will be offered to one group of patients and 2 sessions standard audiological care (psycho-education and sleep hygiene) will be offered to another group. Both groups will be offered sound enrichment at night. In order to take account of the possible effects of clinical contact a third group will be offered 6 sessions of support without a focused tinnitus or sleep intervention. Accepted measures of sleep disturbance will be used as well as measures of tinnitus complaint.
All treatment/contact will be provided at the Royal National Throat Nose & Ear Hospital. Participants will be involved in the study (inc. baseline period {2 weeks}, intervention {8 weeks} and follow-ups {4 and 20 weeks}) for 34 weeks.
Study Overview
Status
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, WC!X 8DA
- Uclh (Rntneh)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least moderately distressing tinnitus (above a set minimum score on the Mini TQ) for at least six months and problematic insomnia (above a set minimum score on the Insomnia Severity Index (ISI) and for tinnitus related insomnia to be identified in clinical interview) as result of tinnitus, for at least three months.
- Patient wishes to work on improving sleep.
- Sufficient understanding of English and sufficient hearing ability to take part in for group discussions and to complete questionnaires.
- Patient has had tinnitus assessed by a doctor and an audiological specialist.
- Willing and able to provide written consent. Able to regularly attend clinic in London, United Kingdom.
Exclusion Criteria:
• Organic sleep disorders present (e.g. Obstructive Sleep Apnoea, delayed phase sleep, etc.) assessed with a subscale of the hospital sleep unit's sleep disorder and snoring proforma.
- Currently pregnant, planning pregnancy or breastfeeding.
- Alcohol or drug dependent.
- Currently suffering with severe mental illness (psychosis, severe anxiety or mood disorder).
- Reports active risk to themselves or others. Still undergoing medical investigations into sleep and / or tinnitus.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Cognitive Behaviour Therapy for Insomnia (CBTi)
A standard CBTi programme for the treatment of primary insomnia, with six, 2 hour, group sessions over eight weeks. There will be minor adaptations for tinnitus, including making specific reference to tinnitus and psycho-education about tinnitus. Every session concludes with provision of a homework task and a sleep diary to complete over the next week. The CBTi course will be supported by providing participants with a CD with some relaxation exercises and a booklet that covers the information given in the session. CBTi includes: Sleep restriction, stimulus control, Sleep hygiene, Relaxation training, Paradoxical intention, Cognitive therapy: Targeting unhelpful beliefs about sleep and worry, Behavioural experiments: Testing unhelpful beliefs and adjusting sleep related behaviour. |
Continuous maintenance of sleep diary, cognitive behaviour therapy, including cognitive restructuring, and behavioural change focusing on sleep restriction and safety behaviours.
|
|
ACTIVE_COMPARATOR: Standard Audiological Care (SAC)
A group intervention that fits with reported audiological treatment of people with tinnitus and significant sleep impairment. This involves psycho-education about tinnitus, habituation, sleep and sleep hygiene. Relaxation will be advised and information provided. A bedside sound generator, as used in routine clinical practice will be provided. Information will be based on standard advice given by hearing therapists/audiologists and will not include specific psychological techniques which are not part of SAC. The group will be generally supportive. SAC tends not to involve repeated meetings; after the initial session, there will be one follow up session 8 weeks later. Follow up will allow for question and answer, and reports on what has been useful. Both sessions will last for 2 hours |
Maintenance of sleep diary at key times.
Psycho-education, provision of bedside sound generator.
|
|
PLACEBO_COMPARATOR: Sleep Support Group (SSG)
Participants will meet in a group, which will offer equivalent contact with therapists and a supportive group milieu as CBTi. It will focus on the potential benefits of a supportive group and will not include specific advice. Participants will complete 2-week sleep diaries as baseline and outcome measures at the four time-points, which will be checked within the session to ensure that participants know how to complete them correctly. The SSG will meet in a group for six sessions, over eight weeks, each of 2 two hours duration. |
Maintenance of sleep diary at key times.
Social support focused on tinnitus and sleep problems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Insomnia Severity Index (ISI) score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
7-item questionnaire, each item rates 0 - 4. Total scores range from 0-28 with higher scores indicating more severity.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in the amount of sleep obtained
Time Frame: A 2-week sleep diary will be kept 2 weeks prior to the first and last treatment sessions and to the 1 and 6 month follow-ups.
|
Average of all of the following metrics obtained from 2 weeks of sleep diary measure: Sleep Onset Latency - lower score indicates better sleep; Wake Time After Sleep Onset - lower score indicate better sleep; Number of night time awakenings - lower scores indicate better sleep; Total Sleep Time - higher scores indicate better sleep; Time in Bed - included only so that Sleep Efficiency can be calculated: Sleep Efficiency (Total Sleep Time / Time in Bed x 100) - higher scores indicate better sleep. Diary measures for sleep quality (0= worst possible to 10=best possible), tinnitus annoyance (0= not at all to 10= extremely), refreshed at waking (0= not at all to 10= very refreshed) and quality of day time functioning (0= very poor to 10= very good). |
A 2-week sleep diary will be kept 2 weeks prior to the first and last treatment sessions and to the 1 and 6 month follow-ups.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pittsburgh Sleep Quality Index score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
10-item questionnaire.
Sum of 7 components; global score range 0 - 21; higher scores indicate worse sleep quality.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Dysfunctional Beliefs and Attitudes About Sleep Questionnaire - abbreviated version (DBAS-16) score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
16-item questionnaire scored on a 0-10 scale.
The average score is calculated from all individual scores and ranges from 0-10; higher scores indicate more dysfunctional / unrealistic beliefs about / sleep.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Tinnitus Catastrophizing Scale score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
13-item questionnaire scored on a 0-4 scale.
Total sum of scores range from 0 - 52.
Higher scores indicate higher levels of catastrophizing.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Mini Tinnitus Questionnaire score
Time Frame: Screening
|
Construct: Tinnitus complaint 12-item questionnaire scored on a 0 - 2 scale.
Total sum of scores range 0-24.
Higher scores indicate presence of tinnitus.
A score of 8 or more indicates the presence of a clinical level of tinnitus-related distress.
|
Screening
|
|
Change in the Tinnitus Questionnaire score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Construct: Tinnitus complaint 41-item questionnaire scored on a 0 - 2 scale.
Total sum of scores ranges from 0-82; higher scores indicate presence of tinnitus.
The reliable change criterion is 11.08.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in subjective measure of tinnitus loudness
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Visual Analogue Scale from 0mm to 100mm; higher scores indicate greater loudness of tinnitus.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Clinical Outcome in Routine Evaluation - Outcome Measure score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Construct: general psychological distress 34-item questionnaire scored on a 0-4 scale.
The average of all the scores is calculated and then multiplied by 10, so the scores can range from 0 to 40; a clinical cut-off score is 10 and clinically significant change is 5.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Patient Health Questionnaire-9 score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Construct: Depression 9-item questionnaire scored on a 0-3 scale; total sum of scores ranges from 0-27 with higher scores indicate greater depression severity.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Generalized Anxiety Disorder Assessment-7 score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
7-items questionnaire scored on a 0-3 scale; total sum of scores ranges from total score range: 0-21 with higher score indicating more severe anxiety.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in EuroQOL score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Construct: health status (dimensions: mobility, self-care, performing usual activities, pain or discomfort; anxiety or depression); each state is referred to in terms of a 5 digit code; The answers given to EQ-5D allow 243 unique health states to be identified and can be converted into EQ-5D index and utility scores anchored at 0 for death and 1 for perfect health.
The EQ-5D questionnaire also includes a Visual Analogue Scale (VAS), by which respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Change in Work and Social Adjustment Scale score
Time Frame: At first and last treatment sessions and at 1 and 6 month follow-ups
|
Construct: impaired functioning 5-item questionnaire scored on a 0-8 scale; total sums of scores range from 0-40 with higher scores indicating greater functional impairment.
|
At first and last treatment sessions and at 1 and 6 month follow-ups
|
|
Satisfaction and feedback
Time Frame: At the end of treatment and at six month follow-up point
|
Questionnaire asking individuals to rate the following on a 0 - 10 scale (from not at all to extremely) How useful was treatment?
How relevant was treatment?
How acceptable was treatment?
They are also asked to provide qualitative feedback in the form of comments in response to questions about what changes they have noticed, what aspects of treatment were most and least useful, what they would have liked to be different and any other comments.
|
At the end of treatment and at six month follow-up point
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laurence Laurence, PhD, UCLH
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UCLondonH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
Clinical Trials on Cognitive Behaviour Therapy for Insomnia
-
Shanghai Jiao Tong University School of MedicineUnknownAutism Spectrum Disorder | Cognitive Behaviour TherapyChina
-
Memorial University of NewfoundlandCanadian Institutes of Health Research (CIHR)CompletedCancer | Insomnia | Cognitive ImpairmentCanada
-
University of ReginaSaskatchewan Centre for Patient-Oriented ResearchCompletedDepression | Insomnia | AnxietyCanada
-
University of Kansas Medical CenterCompletedMultiple SclerosisUnited States
-
University of ArizonaCompletedSleep Initiation and Maintenance DisordersUnited States
-
Stanford UniversityNational Institute of Nursing Research (NINR)Completed
-
Melbourne HealthWilliam Buckland FoundationCompleted
-
Tel Aviv UniversityIsrael Science FoundationRecruiting
-
Hospital Authority, Hong KongUnknown